Profound Medical Corp.
PROF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 136.6% | -15.6% | -50.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 74.3% | 73.2% | 70.7% | 68.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -145.8% | -618% | -419.8% | -226.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -150.8% | -709.9% | -409.2% | -144% |
| EPS Diluted | 0.26 | -0.52 | -0.36 | -0.19 |
| % Growth | 150% | -44.4% | -89.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |